E11even
List Distillery LLC — FORT MYERS, FL
Florida
About E11even
E11even is a vodka brand with origins in Florida. The spirit is produced at an alcohol content within the 80 to 89 proof range, positioning it as a standard-strength vodka offering. According to TTB records, the brand maintains one distinct product group across retail platforms. The label has received three total approvals from the Alcohol and Tobacco Tax and Trade Bureau, with significant approval activity occurring in 2022 and 2024. These recent approvals suggest ongoing product development or reformulation efforts within the brand's portfolio. As a Florida-based vodka producer, E11even operates within the broader American spirits market. The brand's presence in the TTB COLA registry confirms its compliance with federal labeling and compositional standards required for vodka products sold in the United States. The approval timeline indicates the brand's continued presence in the marketplace during the early-to-mid 2020s period.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| E11even VODKA 80-89 PROOF | Vodka 80-89 Proof | Approved | 2024-08-13 | List Distillery LLC |
Page 1 of 1
E11even at a Glance
E11even has 1 distinct product with 3 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2022-02-23 and 2024-08-13. Produced in Florida.
All information sourced from public TTB records.
Are you the owner or distributor of E11even?
Claim this brand listing to update information or get featured. Contact team@buy.vodka.
Produced At
List Distillery LLCRelated Brands
- Muscle also from Florida
- Three Olives also from Florida
- Florida Cane also from Florida
- Ice Pik also from Florida
- Dark Door Spirits also from Florida
- Veil also makes Vodka 80-89 Proof
- Heritage Distilling CO also makes Vodka 80-89 Proof
- Svedka also makes Vodka 80-89 Proof
- Holla also makes Vodka 80-89 Proof
- A.M. Scott Distillery also makes Vodka 80-89 Proof
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.